Tango Therapeutics (TNGX) Cash & Current Investments (2020 - 2025)
Historic Cash & Current Investments for Tango Therapeutics (TNGX) over the last 6 years, with Q3 2025 value amounting to $152.8 million.
- Tango Therapeutics' Cash & Current Investments fell 4789.55% to $152.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $152.8 million, marking a year-over-year decrease of 4789.55%. This contributed to the annual value of $257.9 million for FY2024, which is 2421.07% down from last year.
- Per Tango Therapeutics' latest filing, its Cash & Current Investments stood at $152.8 million for Q3 2025, which was down 4789.55% from $180.8 million recorded in Q2 2025.
- In the past 5 years, Tango Therapeutics' Cash & Current Investments registered a high of $506.1 million during Q3 2021, and its lowest value of $53.2 million during Q2 2021.
- Moreover, its 5-year median value for Cash & Current Investments was $333.6 million (2023), whereas its average is $308.6 million.
- In the last 5 years, Tango Therapeutics' Cash & Current Investments surged by 21268357.94% in 2021 and then plummeted by 4789.55% in 2025.
- Tango Therapeutics' Cash & Current Investments (Quarter) stood at $487.5 million in 2021, then fell by 24.9% to $366.1 million in 2022, then dropped by 7.05% to $340.3 million in 2023, then dropped by 24.21% to $257.9 million in 2024, then tumbled by 40.75% to $152.8 million in 2025.
- Its Cash & Current Investments was $152.8 million in Q3 2025, compared to $180.8 million in Q2 2025 and $216.7 million in Q1 2025.